The tor pathway: a target for cancer therapy

This publication has 166 references indexed in Scilit:

• Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
  Nature Cell Biology, 2003
• Rheb is an essential regulator of S6K in controlling cell growth in Drosophila
  Nature Cell Biology, 2003
• TOR signalling in bugs, brain and brawn
  Nature Reviews Molecular Cell Biology, 2003
• mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
  Cell, 2002
• Myogenic Differentiation Is Dependent on Both the Kinase Function and the N-terminal Sequence of Mammalian Target of Rapamycin
  Published by Elsevier ,2002
• 4E-binding Proteins, the Suppressors of Eukaryotic Initiation Factor 4E, Are Down-regulated in Cells with Acquired or Intrinsic Resistance to Rapamycin
  Journal of Biological Chemistry, 2002
• Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K
  BioEssays, 2002
• The Mammalian Target of Rapamycin Regulates C2C12 Myogenesis via a Kinase-independent Mechanism
  Journal of Biological Chemistry, 2001
• Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?
  Oncogene, 2001
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
  The Journal of Antibiotics, 1975